BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12065407)

  • 1. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence.
    Brookes S; Rowe J; Ruas M; Llanos S; Clark PA; Lomax M; James MC; Vatcheva R; Bates S; Vousden KH; Parry D; Gruis N; Smit N; Bergman W; Peters G
    EMBO J; 2002 Jun; 21(12):2936-45. PubMed ID: 12065407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: implications for cellular senescence.
    Zhu D; Xu G; Ghandhi S; Hubbard K
    J Cell Physiol; 2002 Oct; 193(1):19-25. PubMed ID: 12209876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
    Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
    Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts.
    Huot TJ; Rowe J; Harland M; Drayton S; Brookes S; Gooptu C; Purkis P; Fried M; Bataille V; Hara E; Newton-Bishop J; Peters G
    Mol Cell Biol; 2002 Dec; 22(23):8135-43. PubMed ID: 12417717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence.
    Peeper DS; Shvarts A; Brummelkamp T; Douma S; Koh EY; Daley GQ; Bernards R
    Nat Cell Biol; 2002 Feb; 4(2):148-53. PubMed ID: 11812999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype.
    Milyavsky M; Shats I; Erez N; Tang X; Senderovich S; Meerson A; Tabach Y; Goldfinger N; Ginsberg D; Harris CC; Rotter V
    Cancer Res; 2003 Nov; 63(21):7147-57. PubMed ID: 14612508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of p16(INK4a) to replicative senescence of human fibroblasts.
    Brookes S; Rowe J; Gutierrez Del Arroyo A; Bond J; Peters G
    Exp Cell Res; 2004 Aug; 298(2):549-59. PubMed ID: 15265701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of chicken p15INK4b at senescence and in the developing brain.
    Kim SH; Rowe J; Fujii H; Jones R; Schmierer B; Kong BW; Kuchler K; Foster D; Ish-Horowicz D; Peters G
    J Cell Sci; 2006 Jun; 119(Pt 12):2435-43. PubMed ID: 16720639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The INK4a/ARF locus and melanoma.
    Sharpless E; Chin L
    Oncogene; 2003 May; 22(20):3092-8. PubMed ID: 12789286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock.
    Munro J; Barr NI; Ireland H; Morrison V; Parkinson EK
    Exp Cell Res; 2004 May; 295(2):525-38. PubMed ID: 15093749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
    Palmero I; Murga M; Zubiaga A; Serrano M
    Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
    Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity is sufficient to bypass replicative senescence in human limbal and conjunctival but not corneal keratinocytes.
    Pellegrini G; Dellambra E; Paterna P; Golisano O; Traverso CE; Rama P; Lacal P; De Luca M
    Eur J Cell Biol; 2004 Dec; 83(11-12):691-700. PubMed ID: 15679113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
    Krimpenfort P; Quon KC; Mooi WJ; Loonstra A; Berns A
    Nature; 2001 Sep; 413(6851):83-6. PubMed ID: 11544530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.
    Shvarts A; Brummelkamp TR; Scheeren F; Koh E; Daley GQ; Spits H; Bernards R
    Genes Dev; 2002 Mar; 16(6):681-6. PubMed ID: 11914273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes.
    Drayton S; Rowe J; Jones R; Vatcheva R; Cuthbert-Heavens D; Marshall J; Fried M; Peters G
    Cancer Cell; 2003 Oct; 4(4):301-10. PubMed ID: 14585357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ha-Ras(G12V) induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction.
    Takaoka M; Harada H; Deramaudt TB; Oyama K; Andl CD; Johnstone CN; Rhoades B; Enders GH; Opitz OG; Nakagawa H
    Oncogene; 2004 Sep; 23(40):6760-8. PubMed ID: 15273725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.